Global Infectious Disease Diagnostics Market Size study, By Product (Reagents, Kits, and Consumables, Instruments, Software & Services), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, Other technologies), By Disease Type (HIV, Hepati

Global Infectious Disease Diagnostics Market Size study, By Product (Reagents, Kits, and Consumables, Instruments, Software & Services), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, Other technologies), By Disease Type (HIV, Hepatitis, HPV, Tuberculosis, Influenza, Other Infectious Diseases), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Other End-Users), and Regional Forecasts 2022-2028Global Infectious Disease Diagnostics Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Infectious disease diagnostics is the method by which the foreign antigens or organisms of an infectious disease are identified and characterized. This diagnostic procedure provides information about the causative organism by the usage of numerous diagnosis techniques and instruments, which helps in receiving suitable treatment. The increasing incidences of various infectious diseases, rising awareness for the early detection of diseases by using specific diagnostic tests, and increasing spending on healthcare are bolstering the market demand across the globe. For instance, according to Statista, in 2018, the tuberculosis elimination program in India spends around USD 360 million, and the amount increased and reached USD 400 million in 2021. Thereby, the rising expenditure on the diagnostics and treatment of infectious diseases is exhibiting a positive influence on the growth of the market in the impending years. However, the lack of awareness regarding the availability of treatment options and the dearth of skilled professionals impede the growth of the market over the forecast period of 2022-2028. Also, the rising adoption of technologically advanced visual diagnostic equipment in healthcare organizations and the growing government support and favorable policies are anticipated to act as catalyzing factors for the market demand during the forecast period.

The key regions considered for the global Infectious Disease Diagnostics Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing healthcare spending and availability of advanced healthcare infrastructure facilities. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the execution of favorable government initiatives, as well as the high burden of infections, would create lucrative growth prospects for the Infectious Disease Diagnostics Market across the Asia-Pacific region.

Major market players included in this report are:

Abbott Laboratories
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
BioMérieux SA
Siemens Healthineers AG
Danaher Corporation
Becton, Dickinson and Company
PerkinElmer, Inc.
Hologic, Inc.
Bio-Rad Laboratories, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product Products of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Reagents, Kits, and Consumables
Instruments
Software & Services
By Technology:
Immunodiagnostics
Clinical Microbiology
PCR
INAAT
Other technologies
By Disease Type:
HIV
Hepatitis
HPV
Tuberculosis
Influenza
Other Infectious Diseases
By End-User:
Diagnostic Laboratories
Hospitals & Clinics
Other End-Users
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Infectious Disease Diagnostics Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


Companies Mentioned

Abbott Laboratories
Thermo Fisher Scientific Inc.
F. Hoffmann-La Roche Ltd.
BioMérieux SA
Siemens Healthineers AG
Danaher Corporation
Becton, Dickinson and Company
PerkinElmer, Inc.
Hologic, Inc.
Bio-Rad Laboratories, Inc.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.